In a recent feasibility study, BIDMC tested an anti-epileptic drug for its potential impact on the brain activity of patients with mild Alzheimer's disease. The team documented changes in patients' EEGs that suggest the drug could have a beneficial effect.
Going for a walk outside, reading, listening to music--these and other enjoyable activities can reduce blood pressure for elderly caregivers of spouses with Alzheimer's disease, suggests a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. The journal is published by Wolters Kluwer.
People at risk for Alzheimer's disease who do more moderate-intensity physical activity, but not light-intensity physical activity, are more likely to have healthy patterns of glucose metabolism in their brain, according to a new UW-Madison study. Results of the research were published today online in Journal of Alzheimer's Disease.
Researchers from ITMO University have built a setup for recording holograms of tiny objects like living cells with a femtosecond speed. The new method allows one to reconstruct phase topography of a studied sample according to deformations that emerge in a laser pulse when it passes through the specimen. In comparison to electron microscopes, the device can visualize transparent biological structures without introducing contrast agents. The paper was published in Applied Physics Letters.
InSysBio scientific group led by Tatiana Karelina developed a quantitative system pharmacology model of Alzheimer's disease. First part published in CPT Pharmacometrics & Systems Pharmacology shows how to design initial phases of clinical trials of new drugs and to interpret the data obtained.
Researchers at the University of Cambridge have designed antibodies that target the protein deposits in the brain associated with Alzheimer's disease, and stop their production.
The Mediterranean diet is associated with a variety of health benefits, including a lower incidence of dementia. Now, researchers at Temple's Lewis Katz School of Medicine have identified a specific ingredient that protects against cognitive decline: extra-virgin olive oil. In a new study, the researchers show that consumption of extra-virgin olive oil protects memory and learning ability and reduces the formation of amyloid-beta plaques and neurofibrillary tangles in the brain -- classic markers of Alzheimer's disease.
After years of living with Parkinson's Disease approximately 25% of patients experience deficits in cognition that impair function. A new research tool may help predict a patient's risk for developing dementia and could enable clinical trials aimed at finding treatments to prevent the cognitive effects of the disease.
A plant extract used for centuries in traditional medicine in Nigeria could form the basis of a new drug to treat Alzheimer's disease, researchers at The University of Nottingham have found.
A position statement on the use of hormone therapy for menopausal and postmenopausal women from The North American Menopause Society (NAMS) has been published online in Menopause. 'The goal of the Society's position statement is to provide excellent, evidence-based, current clinical recommendations to menopause practitioners for the improvement of care for women depending on them to help relieve menopause symptoms,' says Dr. JoAnn Pinkerton, NAMS executive director.